Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Shares Slide 10 Percent on Q3 Losses and Lay-Offs

NEW YORK, Oct. 28 (GenomeWeb News) - Shares in Gene Logic were down 10.7 percent, or $.46, at $3.83 in mid-afternoon trading after the company reported today that its third-quarter net loss more than doubled.


The losses were related to the impairment of goodwill for its 2003 TherImmune Research acquisition, the company said.


Gene Logic also revised its full year revenue projections downwards and announced lay-offs.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.